Jeffrey Lipman's Publications

About Jeffrey Lipman's Publications

Honorary Professorial Fellow

  • A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial

    BMJ Open Date published:

  • Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains

    International Journal of Antimicrobial Agents Date published:

  • Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?

    Intensive Care Medicine Date published:

  • A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy

    Journal of Antimicrobial Chemotherapy Date published:

  • Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients

    Journal of Antimicrobial Chemotherapy Date published:

  • Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

    International Journal of Antimicrobial Agents Date published:

  • Defining Antibiotic Dosing in Lung Infections

    Clinical Pulmonary Medicine Date published:

  • Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing

    Intensive Care Medicine Date published:

  • How should we dose antibiotics for pneumonia in the ICU?

    Current Opinion in Infectious Diseases Date published:

  • Reply to Soman et al

    Clinical Infectious Diseases Date published:

  • β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

    International Journal of Antimicrobial Agents Date published:

  • Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations

    Journal of Neurosurgery Date published:

  • Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*

    Critical Care Medicine Date published:

  • CLINICAL DETERMINANTS OF NON TARGET ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING BETA-LACTAM ANTIBIOTICS: RESULTS FROM THE DALI STUDY

    Date published:

  • Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

    Critical Care Date published:

  • Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients

    Critical Care Date published: